Cornercap Investment Counsel Inc. Sells 15,221 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Cornercap Investment Counsel Inc. trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 49.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,835 shares of the company’s stock after selling 15,221 shares during the quarter. Cornercap Investment Counsel Inc.’s holdings in Option Care Health were worth $496,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the business. UMB Bank n.a. boosted its stake in shares of Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after purchasing an additional 750 shares during the last quarter. GAMMA Investing LLC boosted its stake in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after purchasing an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its stake in shares of Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after purchasing an additional 1,446 shares during the last quarter. Blue Trust Inc. lifted its position in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock valued at $81,000 after acquiring an additional 377 shares during the period. Finally, SageView Advisory Group LLC acquired a new position in shares of Option Care Health during the 1st quarter valued at $85,000. 98.05% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

OPCH has been the topic of a number of research reports. JMP Securities boosted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. The Goldman Sachs Group downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their target price for the company from $38.00 to $27.00 in a research report on Monday, November 4th. Truist Financial dropped their target price on shares of Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Barrington Research lowered their price objective on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a report on Thursday, October 31st. Finally, Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $30.83.

Option Care Health Stock Performance

Shares of OPCH stock opened at $21.93 on Friday. The company has a market cap of $3.73 billion, a P/E ratio of 18.43, a P/E/G ratio of 2.30 and a beta of 1.32. The firm has a 50-day moving average of $28.62 and a 200-day moving average of $29.38. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a one year low of $21.64 and a one year high of $34.63.

Insider Activity at Option Care Health

In other Option Care Health news, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares in the company, valued at $7,654,461.15. This trade represents a 8.58 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the completion of the transaction, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is owned by company insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.